Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Azelaic acid - a new topical drug for acne

Article Abstract:

Azelaic acid cream (Azelex) for mild to moderate acne may be as effective as other forms of acne treatments, while causing fewer side effects. Azelaic acid, sold as a 20% cream, has both antibacterial and antikeratinizing properties. Azelaic acid produced similar results compared to benzoyl peroxide, tretinoin, or erythromycin. At least 60% of patients with mild to moderate acne responded well to azelaic acid. Severe acne, however, seems to require oral isotretinoin in order to lower sebaceous gland secretion. Burning and itching episodes are apparently rare during the usage of azelaic acid. Dark complexions may experience changes in pigmentation, according to the manufacturer.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1996
Azelex (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Adapalene for acne

Article Abstract:

Adapalene is effective in treating acne and may have fewer side effects than tretinoin. Sold under the trade name Differin, it is a synthetic retinoid. It comes in gel form and is applied to the skin. It is as effective as 0.025% tretinoin gel and was better tolerated. It is less expensive than many forms of tretinoin.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1997
Differin (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Blue light (ClearLight) for Acne vulgaris

Article Abstract:

Clinical testing reveals that the high-intensity narrow band blue light (ClearLight) can be used for treatment of acne. However, its safety and effectiveness are not evaluated. Dry skin and mild warmth sensation are the only adverse reactions. It is free of the carcinogenic ultraviolet light. It is FDA approved.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 2003
United States, Drug use, Blue light, Monochromatic light

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Evaluation, Product/Service Evaluation, Drug therapy, Acne
Similar abstracts:
  • Abstracts: Preparing for change? Time for a change of agenda. Satisfied customers: a new system for dealing with patients' complaints is due to start at the beginning of next month. Not all nurses are ready for the change
  • Abstracts: Keeping the doctor away. Remedial action. Unseen and unheard: the plight of children whose parents have HIV or AIDS is notrecognised by many support services. Nurses have been called to help put the recordstraight
  • Abstracts: Adolescent medicine. The adolescent viewpoint: implications for access and prevention. The National Longitudinal Study on Adolescent Health: preliminary results
  • Abstracts: A 50-year-old man with the onset of fever and diarrhea in Morocco. A 40-year-old woman with rapid onset of flaccid paraplegia
  • Abstracts: Recurrent aphthous ulcers: a review of diagnosis and treatment. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.